AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study

CONCLUSION: A single ABO treatment provided rapid and effective improvements in glabellar line severity at all doses. Higher doses tended to demonstrate elevated response rates and longer duration of effect. All ABO doses were well-tolerated with low TEAE incidence. J Drugs Dermatol. 2021;20(9):980-987. doi:10.36849/JDD.6263.PMID:34491016 | DOI:10.36849/jdd.6263

Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: John Joseph Amir Moradi Z Paul Lorenc Kyle Coleman Glynis Ablon Joely Kaufman-Janette Sue Ellen Cox Andrew Campbell Steven Dayan Anna-Karin Berg Girish Munavalli Source Type: research